Additionally, the majority of samples exhibit nuclear staining of the protein, and the proportion of FOXO3 protein down-regulation was significant with breast cancer III and IV stages, oestrogen receptor, tumour size, molecular subtype, and highly significant lymph node status (Table 3; Figure 3). The gene discussed is FOXO3; the disease is breast carcinoma.